Abstract:
Introduction: Chronic tonsilitis in children is one of the most common pathologies in pediatric
otolaryngology practice. The main factors in development of chronic tonsilitis are: microbial factor, decreased immunity, predisposing factors.
Purpose: To determine the etiopathogenic role of microbial factor in the development of chronic
tonsilitis in children.
Materials and methods: Microbial flora was examined at 34 patients diagnosed with compensated
chronic tonsillitis at different parts of the pharynx: the surface of the tonsils, the tonsil gaps and nasopharynx. 19 patients were examined to the presence of fungi.
Results: The bacteriological examination of microbial flora in the pharynx at 34 children diagnosed
with chronic compensated tonsillitis appreciated the following microorganisms: Staphylococcus aureus
- 33%; Streptococcus pneumoniae - 28%; Enterococcus - 26%; E. coli - 5%; Streptococcus B-hemolitic
- 2%; K. oxytoco - 2%; Pseudomonas - 2%; Haemoph. influenzae - 2%.
From 19 children examined at the presence of fungi in the pharynx, at 3 children was found Candida
albicans (15,8%) associated with microbial flora.
Analyzing the results of bacteriological examinations from different areas of the pharynx- the surface
of the tonsils, the tonsil gaps and in the nasopharynx, it was found that the microbial flora in these areas
is the same in 53,3%, and it is different in 46,7%. Analyzing the results from the surface of the tonsils
and from the tonsil gaps, it was found that the microbial flora in these areas is the same in 73,7%, it is
combined in 20,6% and it is different in 5,9%. Analyzing the results from the tonsil gaps and the nasopharynx, it was found that the microbial flora in these areas is the same in 62,1%, it is combined in 20,7%
and it is different in 17,2%. Analyzing the results from the surface of the tonsils and nasopharynx, it was
found that the microbial flora in these areas is the same in 64,7%, it is combined in 20,6% and it is different in 14,7%.
Having examined the degree of microbial activity of Staph.aureus (according to scale from 1 to 4 “+”)
it was found the following results: “++++” 13 cases (32,5%), “+++” 12 cases (30%), “+” 8 cases (20%),
“++” 7 cases (17,5%). Having examined the degree of microbial activity of Strept.pneumoniae (according
to scale from 1 to 4 “+”) it was found the following results: “+++” 18 cases (54,6%), “++” 8 cases (24,2%),
“++” 7 cases (21,2%). Having examined the degree of microbial activity of (according to scale from 1 to
4 “+”) it was found the following results: “+++” 18 cases (51,4%), “++++” 16 cases (45,7%), “+” 1 case
(2,9%).
Having examined the sensitivity of the agents detected to the main groups of antibiotics it was established that in most cases the microbial flora is sensitive to B lactamic antibiotics, namely amoxicillin/
clavulanic acid - 97%, and amoxicillin - 82,3%. To the cephalosporin group the sensitivity was 79,4%, to
the macrolide group - 55-65% cases. The highest resistance of the microbial agents was showed to be to
penicillin - 70,6%, and trimethoprim/sulfametazon - 69,0%.
Conclusions: Analyzing the results of bacteriological examinations of microbial flora in different
pharyngeal areas, was established that the microbial flora in these areas is often the same.
The bacteriological examination of microbial flora in the pharynx at the examined group appreciated
that most often are found the following microorganisms:Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus, and rarely other pathogens. From the group of children examined to the presence of fungi in pharynx, Candida albicans was found in 15,8% cases.
The examnination of sensitivity to the main groups of antibiotics of the agents detected in the pharynx, it was established that in most cases the microbial flora is sensitive to the group of B lactamic antibiotics (Amoxicillin/clavulanic acid and amoxicillin), it is less sensitive to the cephalosporin group, and
less sensitive to the macrolide group. The highest resistance of the microbial agents it was shown to be to
the penicillin and trimethoprim/sulfametazon.